Search Within

Department of Medicine

Formats
  1. Journal Article (19593)
  2. Meeting Abstract (16038)
  3. Review (1150)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22321)
  2. Hematologic Malignancies, Division of (13278)
  3. Center for Hematologic Malignancies (11061)
  4. GSK Faculty (10646)
  5. Survivorship Research (9330)
  6. Division of Subspecialty Medicine (7535)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1071)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2111)

More Publishers

Results (39622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Malignancies of the upper gastrointestinal tract
    Editorial

    Ilson, D. H.
    Hematology/Oncology Clinics of North America (2024)

    Fulltext@MSK | Save
  • Advances in human epidermal growth factor receptor 2-targeted therapy in upper gastrointestinal cancers
    Review

    Lee, J.; Ku, G.
    Hematology/Oncology Clinics of North America (2024)

    Fulltext@MSK | Save
  • Advances in systemic therapy in pancreatic cancer
    Review

    Yu, K. H.
    Hematology/Oncology Clinics of North America (2024)

    Fulltext@MSK | Save
  • Immunotherapy: A sharp curve turn at the corner of targeted therapy in the treatment of biliary tract cancers
    Review

    Al Mahmasani, L.; Harding, J. J.; Abou-Alfa, G.
    Hematology/Oncology Clinics of North America (2024)

    Fulltext@MSK | Save
  • Moving towards establishing centres of excellence in cardiac amyloidosis: An International Cardio-Oncology Society statement
    Review

    Cheng, R.; Kittleson, M. M.; Wechalekar, A. D.; Alvarez-Cardona, J.; Mitchell, J. D.; Scarlatelli Macedo, A. V.; Dutra, J. P. P.; Campbell, C. M.; Liu, J. E.; Landau, H. J.; more...
    Heart (2024)

    Fulltext@MSK | Save
  • Predicting drug–drug interactions in breast cancer patients treated with CDK4/6 inhibitors and forward planning
    Review

    Kulkarni, A.; Singh, J.
    Expert Opinion on Drug Metabolism and Toxicology (2024)

    Fulltext@MSK | Save
  • Health-related quality of life in patients with previously treated advanced urothelial carcinoma from EV-301: A phase 3 trial of enfortumab vedotin versus chemotherapy
    Journal Article

    Rosenberg, J. E.; Mamtani, R.; Sonpavde, G. P.; Loriot, Y.; Duran, I.; Lee, J. L.; Matsubara, N.; Vulsteke, C.; Castellano, D.; Sridhar, S. S.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Clinical pharmacology of the antibody–drug conjugate enfortumab vedotin in advanced urothelial carcinoma and other malignant solid tumors
    Review

    Tang, M.; Garg, A.; Bonate, P. L.; Rosenberg, J. E.; Matsangou, M.; Kadokura, T.; Yamada, A.; Choules, M.; Pavese, J.; Nagata, M.; more...
    Clinical Pharmacokinetics (2024)

    Fulltext@MSK | Save
  • Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation
    Journal Article

    Major-Monfried, H.; Hosszu, K.; McAvoy, D. P.; Vallone, A.; Shukla, N.; Gillio, A.; Spitzer, B.; Kung, A. L.; Cancio, M.; Curran, K.; more...
    Cytotherapy (2024)

    Fulltext@MSK | Save
  • A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers
    Review

    Liu, Y. L.; Weigelt, B.
    Cancer (2024)

    Fulltext@MSK | Save